Literature DB >> 11668042

Capsaicin vanilloid receptor-1 mediates substance P release in experimental pancreatitis.

J D Nathan1, A A Patel, D C McVey, J E Thomas, V Prpic, S R Vigna, R A Liddle.   

Abstract

We examined whether the capsaicin vanilloid receptor-1 (VR1) mediates substance P (SP) release from primary sensory neurons in experimental pancreatitis. Pancreatitis was achieved by 12 hourly injections of caerulein (50 microg/kg ip) in mice. One group received capsazepine (100 micromol/kg sc), a competitive VR1 antagonist, at 4-h intervals. Neurokinin-1 receptor (NK1R) internalization in acinar cells, used as an index of endogenous SP release, was assessed by immunocytochemical quantification of NK1R endocytosis. The severity of pancreatitis was assessed by measurements of serum amylase, pancreatic myeloperoxidase (MPO) activity, and histological grading. Caerulein administration caused significant elevations in serum amylase and pancreatic MPO activity, produced histological evidence of pancreatitis, and caused a dramatic increase in NK1R endocytosis. Capsazepine treatment significantly reduced the level of NK1R endocytosis, and this was associated with similar reductions in pancreatic MPO activity and histological severity of pancreatitis. These results demonstrate that repeated caerulein stimulation causes experimental pancreatitis that is mediated in part by stimulation of VR1 on primary sensory neurons, resulting in endogenous SP release.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11668042     DOI: 10.1152/ajpgi.2001.281.5.G1322

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  34 in total

Review 1.  Transient receptor potential (TRP) channels as drug targets for diseases of the digestive system.

Authors:  Peter Holzer
Journal:  Pharmacol Ther       Date:  2011-03-21       Impact factor: 12.310

2.  Ablation of sensory neurons in a genetic model of pancreatic ductal adenocarcinoma slows initiation and progression of cancer.

Authors:  Jami L Saloman; Kathryn M Albers; Dongjun Li; Douglas J Hartman; Howard C Crawford; Emily A Muha; Andrew D Rhim; Brian M Davis
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-29       Impact factor: 11.205

3.  Role of CXCR2 and TRPV1 in functional, inflammatory and behavioural changes in the rat model of cyclophosphamide-induced haemorrhagic cystitis.

Authors:  Fabiana N Dornelles; Edinéia L Andrade; Maria M Campos; João B Calixto
Journal:  Br J Pharmacol       Date:  2014-01       Impact factor: 8.739

Review 4.  Adipose Tissue and Energy Expenditure: Central and Peripheral Neural Activation Pathways.

Authors:  Magdalena Blaszkiewicz; Kristy L Townsend
Journal:  Curr Obes Rep       Date:  2016-06

Review 5.  Gastrointestinal roles for proteinase-activated receptors in health and disease.

Authors:  A Kawabata; M Matsunami; F Sekiguchi
Journal:  Br J Pharmacol       Date:  2007-11-12       Impact factor: 8.739

6.  Effects of sensory denervation by neonatal capsaicin administration on experimental pancreatitis induced by dibutyltin dichloride.

Authors:  Tsukasa Ikeura; Yosky Kataoka; Taketoshi Wakabayashi; Tetsuji Mori; Yasuharu Takamori; Shoichiroh Takamido; Kazuichi Okazaki; Hisao Yamada
Journal:  Med Mol Morphol       Date:  2007-09-18       Impact factor: 2.309

7.  TRPV1 and TRPA1 antagonists prevent the transition of acute to chronic inflammation and pain in chronic pancreatitis.

Authors:  Erica S Schwartz; Jun-Ho La; Nicole N Scheff; Brian M Davis; Kathryn M Albers; G F Gebhart
Journal:  J Neurosci       Date:  2013-03-27       Impact factor: 6.167

8.  Viewpoints on Acid-induced inflammatory mediators in esophageal mucosa.

Authors:  Karen M Harnett; Florian Rieder; Jose Behar; Piero Biancani
Journal:  J Neurogastroenterol Motil       Date:  2010-10-30       Impact factor: 4.924

9.  HCl-activated neural and epithelial vanilloid receptors (TRPV1) in cat esophageal mucosa.

Authors:  Ling Cheng; Suzanne de la Monte; Jie Ma; Jie Hong; Ming Tong; Weibiao Cao; Jose Behar; Piero Biancani; Karen M Harnett
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-04-23       Impact factor: 4.052

10.  TRPV1: a target for next generation analgesics.

Authors:  Louis S Premkumar; Parul Sikand
Journal:  Curr Neuropharmacol       Date:  2008-06       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.